Browse > Article

Inhibiton of MMP-13 mRNA expression by Doxycycline combination with Mefenamic Acid in the rat Periodontal ligament cells  

Seo, Jin-Hee (Dept. of Periodonology, Chonnam National University, Graduate School, Dept. of Dental Science, Chonnam National University)
Ciu, De-Zhe (Graduate School, Dept. of Dental Science, Chonnam National University, Dental Science Research Institute, Chonnam National University)
Kim, Young-Joon (Dept. of Periodonology, Chonnam National University, Dental Science Research Institute, Chonnam National University)
Publication Information
Journal of Periodontal and Implant Science / v.35, no.1, 2005 , pp. 99-109 More about this Journal
Abstract
It has been focused on the importance of the host inflammatory response in periodontal pathogenesis and progression, treatment has been introduced to control the host response and the method, which diminishes production and activity of MMP by doxycycline, has been used in periodontal field. MMP is a proteolytic enzyme which plays a major role in tissue destruction and MMP-1 is secreted in the periodontally healthy tissue, while MMP-8, 9, 13, etc in the inflammatory state. Among these, MMP-13 has been discovered lately and reported to degrade primarily type II collagen. Periodontal ligament (PDL) cell plays a role in destruction of periodontal tissue. This study was to evaluate the effect of doxycycline and mefenamic acid, non-steroidal antiinflammatory drug on MMP-13 mRNA expression in the rat PDL cell. Doxycycline concentration of $1{\sim}100\;{\mu}g/ml$ was added rat PDL cell and cell activity was measured by MIT assay at day 1 and 3. MMP-13 gene expression was evaluated by RT-PCR after PDL cells were pre-treated for 1hour with doxycycline (50 ${\mu}g/ml$) alone or with mefenamic acid ($10^{-6}M$), then added $IL-1{\beta}$(1.0 ng/ml) and incubated for 16-18 hours. The results are as follows: 1. Cell activity decreased Significantly at 24 and 72 hours in 100 ${\mu}g/ml$ (p<0.05). 2. Level of MMP-13 mRNA was in 20.2% increase by $IL-1{\beta}$ and in pre-treating doxycycline group, expression of $IL-1{\beta}$ induced MMP-13 mRNA was inhibited by 31% than $IL-1{\beta}$ treated only. 3. Mefenamic acid did not inhibit on the expression of $IL-1{\beta}$ induced MMP-13 mRNA, while mefenamic acid in combination with doxycycline inhibited the expression by 41% compared to only $IL-1{\beta}$ stimulation. These results suggest that doxycycline synergistically inhibit the expression of $IL-1{\beta}$ induced MMP-13 mRNA in combination with mefenamic acid.
Keywords
rat periodontal ligament cell; MMP-13; doxycycline; NSAIDs; RT-PCR;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol 1993;64:474-484   PUBMED
2 Golub LM, Ciancio S, Ramamamurthy NS, Leung M, McNamara TF. Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans. J Periodont Res 1990;25:321-330   DOI   PUBMED
3 Smith GN Jr, Mickler EA, Hasty KA, Brandt KD. Specificity of inhibition of matrix metalloproteinase activity by doxycycline: relationship to structure of the enzyme. Arthritis Rheum 1999;42:1140-1146
4 Greenwald RA, Moak SA, Ramamurthy NS, Golub LM. Tetracycline suppresses metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorates bone damage. J Rheumatol 1992;19:927-938   PUBMED
5 Thomas J, Metheny R, Karakioris JM, Wetzel M, Crout R. Long-term subantimicrobial doxycycline (Periostat) as adjunctive management in adult periodontitis. 1. Effects on subgingival bacterial population dynamics. Adv Dent Res 1998;12:32-39   DOI   ScienceOn
6 Cohen DM, Lee HM, Bhattacharyya I, Sensat ML, Payne JB, Golub LM. Effective treatment for cicatricial pemphigoid using a novel combination therapy. J Clin Oncol 2001;19:584-592   PUBMED
7 Wasil M, Halliwell B, Moorhouse CP. Scavenging of hypochlorose acid by tetracycline, rifampicin and some other antibiotics: a possible antioxidant action of rifampicin and tetracycline? Biochem Pharmacol 1988;37;775-778   DOI   ScienceOn
8 Ramamurthy NS, Vernillo AT, Greenwald RA, Lee HM, Sorsa T, Golub LM, Rifkin BR. Reactive oxygen species activate and tetracyclines inhibit rat osteoblast collagenase. J Bone and Miner Res 1993;8:1247-1253
9 Nip LH, Uitto VJ, Golub LM. Inhibition of epithelial cell matrix metalloproteinases by tetracyclines. J Periodont Res 1993;28:379-385   DOI   ScienceOn
10 Golub L, Lee H, Greenwald R, Ryan M, Sorsa T, Salo T, Giannobile W. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragment and bone-type collagenase in gingival crevicular fluid during adult periodontitis. Inflam Res 1997;4:310-319
11 Skidmore R, Walker C, Kouach R, Thomas J, Bradshaw M, Leyden J, Powala C, Ashley R. Effects of sub-antimicrobial dose doxycycline in the treatment of moderate acne. Arch Dermatol 2003;139:459-464   DOI   ScienceOn
12 Kirkwood K, Martin T, Agnello K, Kim YJ. Differential regulation of MMP-13 by chemical modified tetracycline in osteoblasts. J Int Acad Peiodontol 2004;6:39-46
13 Ramamurthy NS, Greenwald RA, Moak S. CMT/tenidap treatment inhibits TMJ destruction in adjuvant arthritis (AA) rats. Ann NY Acad Sci 1994;732:140-151   DOI   PUBMED
14 Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, Decarlo A, Engler JA. Matrix metalloprotenases. A review. Crit Rev Oral Biol Med 1993;4:197-250   PUBMED
15 Walker C, Thomas J, Nango S, Lennon J, Wetzel J, Powala C. Long-term treatment with subantimicrobial dose doxycycline exerts no antibacterial effect on the subgingival microflora associated with adult periodontitis. J Periodontol 2000;71:1465-1471   DOI   ScienceOn
16 Fullmer H, Gibson W. Collagenolytic activity of gingivae of man. Nature 1966;209;728-729   DOI   ScienceOn
17 Lee HM, Cinacio S, Tuter G, Ryan ME, Komaroff E, Golub LM. Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinases inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal antiinflammatory drug. J Periodontol 2004;75:453-463   DOI   ScienceOn
18 Nishikawa M, Yamaguchi Y, Yoshitake K, Seaki Y. Effects of TNFalpha and prostaglandin E2 on the expression of MMPs in human periodontal ligament fibroblasts. J Periodont Res 2002;37:167-76   DOI   ScienceOn
19 Ejeil AL, Igondjo-Tchen S, Ghomrasseni S, Pellat B, Godeau G, Gogly B. Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMP) in healthy and diseased human gingiva. J Periodontol 2003;74:188-195   DOI   ScienceOn
20 Golub LM, Suomalainen K, Sorsa T. Host modulation with tetracyclines and their chemically-modified analogs. Curr Op Dent 1992;2:80-90
21 MacNaul KL., Chartrain N, Lark M, Tocci MJ, Hutchinson NI. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-I and tumor necrosis factor-alpha on stromelysin expression. J Bio Chem 1990;265:17238-17245
22 Ryan ME, Ashley RA. How do tetracycline work? Adv Dent Res 1998;12:149-151   DOI   ScienceOn
23 Ryan ME, Ramamurthy NS, Golub LM. Matrix metalloprotinases and their inhibition in periodontal treatment. Curr Opin Periodontol 1996;3:85-96   PUBMED
24 Preshaw PM, Hefti AF, Jepsen S, Etienne D, Walker C, Bradshaw MH. Subantimicrobial dose doxycycline as adjunctive treatment for periodontitis. A review. J Clin Periodontol 2004;31:697-707   DOI   ScienceOn
25 Freije JMP, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J, Lopez-Ortin C. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinse produced by breast carcinomas. Biol Chem 1994;269:16766-16773
26 Golub LM, Sorsa T, Lee HM , Ciancio S, Sorbi D, Ramamurthy N S, Gruber B, Salo T, Konttinen YT. Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol 1995;22:100-109   DOI   PUBMED   ScienceOn
27 Matsuda N, Lin WL, Kumar NM, Cho MI, Genco RJ. Mitogenic chemotactic and synthetic responses of rat periodontal fibroblastic cells to polypeptide growth factors in vitro. J Periodontol 1992;63:515-525   DOI   PUBMED
28 Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T. Tetracyclines inhibit connective tissue break down by multiple non-antimicrobial mechanisms. Adv Dent Res 1998;12:12-26   DOI   ScienceOn
29 Kapusnik-Uner JE, Sande MA, Chambers HF, Tetracycline, chlormphenicol, erythromycin and miscellaneous antibacterial agents, In: J. G, Hardman, I. E. Limbird, P, B. Molinoff, R. W. Ruddon, A, G, Gilman (eds.), The pharmacological basis of therapeutics, New York: McGraw-Hill, Health Professions Division 1996:1123-1153
30 Uitto VJ, Airola K, Vaalamo M, Johansson N, Putnins EE, Firth JD, Salonen J, Lopez-Otin C, Saarialho-Kere U, Kahari VM. Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation. Am J Pathol 1998;152:1489-1499
31 Chang YC, Yang SF, Lai CC, Liu JY, Hsieh YS. Regulation of matrix metalloproteinase production by cytokines, pharmacological agents and periodontal pathogens in human periodontal ligament fibroblast cultures. J Periodontal Res 2002;37:196-203   DOI   ScienceOn
32 Offenbacher S. Periodontal diseases: pathogenesis. Ann Periodontol 1996;1:821-878   DOI   PUBMED   ScienceOn
33 조종희, 김상목, 김병옥, 한경윤. 테트라사이클린계 약물이 치은섬유아세포내 MMP-13의 활성도에 미치는 영향. 대한치주과학회지 1999;29:677-691
34 Sakellari D, Goodson JM, Socransky SS, Kolokotronis A. Concentration of 3 tetracyclines in plasma, gingival crevice fluid and saliva. J Clin Periodontol 2000;27:53-60   DOI   ScienceOn
35 Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial actions. Adv Dent Res 1998;12:12-26   DOI   ScienceOn
36 Caton JG. Evaluation of Periostat for patient management. Compend Con tin Educ Dent 1999;20:451-456